CSIMarket
 


Zimmer Biomet Holdings Inc   (ZBH)
Other Ticker:  
 
 

ZBH's Capital Expenditures Growth by Quarter and Year

Zimmer Biomet Holdings Inc 's Capital Expenditures results by quarter and year




ZBH Capital Expenditures (in millions $) FY 2024 FY 2023 FY 2022 FY 2021
IV Quarter December - 62.80 63.40 71.50
III Quarter September 164.10 97.40 47.20 54.20
II Quarter June 40.20 170.60 40.90 27.30
I Quarter March 67.60 46.70 36.40 27.40
FY   271.90 377.50 187.90 180.40



ZBH Capital Expenditures third quarter 2024 Y/Y Growth Comment
Zimmer Biomet Holdings Inc achieved in the third quarter 2024, above Company average Capital Expenditures rise of 68.48% year on year, to $ 164.10 millions.

Looking into third quarter 2024 results within Medical Equipment & Supplies industry 11 other companies have achieved higher Capital Expenditures growth. While Zimmer Biomet Holdings Inc ' s Capital Expenditures jump of 68.48% ranks overall at the positon no. 229 in the third quarter 2024.




ZBH Capital Expenditures ( Y/Y Growth %) 2024
2023 2022 2021
IV Quarter December - -0.95 % -11.33 % 154.45 %
III Quarter September 68.48 % 106.36 % -12.92 % 77.12 %
II Quarter June -76.44 % 317.11 % 49.82 % 43.68 %
I Quarter March 44.75 % 28.3 % 32.85 % -31.84 %
FY   - 100.9 % 4.16 % 53.01 %

Financial Statements
Zimmer Biomet Holdings Inc 's third quarter 2024 Capital Expenditures $ 164.10 millions ZBH's Income Statement
Zimmer Biomet Holdings Inc 's third quarter 2023 Capital Expenditures $ 97.40 millions Quarterly ZBH's Income Statement


ZBH Capital Expenditures (Quarter on Quarter Growth %)

2024
2023 2022 2021
IV Quarter December - -35.52 % 34.32 % 31.92 %
III Quarter September 308.21 % -42.91 % 15.4 % 98.53 %
II Quarter June -40.53 % 265.31 % 12.36 % -0.36 %
I Quarter March 7.64 % -26.34 % -49.09 % -2.49 %
FY (Year on Year)   - 100.9 % 4.16 % 53.01 %




Capital Expenditures third quarter 2024 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #12
Healthcare Sector #28
Overall #229

Capital Expenditures Y/Y Growth Statistics
High Average Low
196.76 % 31.03 % -74.18 %
(Jun 30 2019)   (Mar 31 2021)
Capital Expenditures third quarter 2024 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #12
Healthcare Sector #28
Overall #229
Capital Expenditures Y/Y Growth Statistics
High Average Low
196.76 % 31.03 % -74.18 %
(Jun 30 2019)   (Mar 31 2021)

Capital Expenditures by Quarter for the Fiscal Years 2021, 2022, 2023, 2024

Zimmer Biomet Holdings Inc 's Q/Q Capital Expenditures Growth


Capital Expenditures Q/Q Growth Statistics
High Average Low
578.57 % 32.16 % -77.15 %
(Jun 30 2019)  


ZBH's III. Quarter Q/Q Capital Expenditures Comment
Zimmer Biomet Holdings Inc achieved in the III. Quarter 2024 above company average sequential Capital Expenditures doubling of 308.21%, to $ 164.10 millions, from $40.20 millions in the second quarter.
Medical Equipment & Supplies company is impressively improving, not just claiming better then normal growth, and additionally improving pace.

Within Medical Equipment & Supplies industry 2 other companies have achieved higher Capital Expenditures quarter on quarter growth. While Zimmer Biomet Holdings Inc 's Capital Expenditures growth quarter on quarter, overall rank is 24.


Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #3
Healthcare Sector #4
Overall #24
Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #3
Healthcare Sector #4
Overall #24
Capital Expenditures Q/Q Growth Statistics
High Average Low
578.57 % 32.16 % -77.15 %
(Jun 30 2019)  


ZBH's III. Quarter Q/Q Capital Expenditures Comment
Zimmer Biomet Holdings Inc achieved in the III. Quarter 2024 above company average sequential Capital Expenditures doubling of 308.21%, to $ 164.10 millions, from $40.20 millions in the second quarter.
Zimmer Biomet Holdings Inc is impressively improving, not only recording above regular growth, and also accelerating pace.

Within Medical Equipment & Supplies industry 2 other companies have achieved higher Capital Expenditures quarter on quarter growth. While Zimmer Biomet Holdings Inc 's Capital Expenditures growth quarter on quarter, overall rank is 24.


Zimmer Biomet Holdings Inc 's 12 Months Capital Expenditures Growth Year on Year


Capital Expenditures TTM Growth

12 Months Ending
(Sep 30 2024)
12 Months Ending
(Jun 30 2024)
12 Months Ending
(Mar 31 2024)
12 Months Ending
(Dec 31 2023)
12 Months Ending
(Sep 30 2023)
Cumulative Capital Expenditures 12 Months Ending $ 334.70 $ 268.00 $ 398.40 $ 377.50 $ 378.10
Y / Y Capital Expenditures Growth (TTM) -11.48 % -18.27 % 101.01 % 100.9 % 92.91 %
Year on Year Capital Expenditures Growth Overall Ranking # 34 # 310 # 0 # 0 # 366
Seqeuential Capital Expenditures Change (TTM) 24.89 % -32.73 % 5.54 % -0.16 % 15.31 %
Seq. Capital Expenditures Growth (TTM) Overall Ranking # 229 # 295 # 0 # 0 # 1489


Cumulative Capital Expenditures growth Comment
Zimmer Biomet Holdings Inc showed decline, but improvement compare to trailing twelve month Capital Expenditures decrease in Jun 30 2024. If the fiscal year would end in Sep 30 2024, Zimmer Biomet Holdings Inc 's annual Capital Expenditures growth would be -11.48% year on year to $335 millions.

Among companies within the Healthcare sector 4 other companies have achieved higher trailing twelve month Capital Expenditures growth. While Total ranking has impoved so far to 34, from total ranking in previous quarter at 310.

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
196.76 %
31.03 %
-74.18 %
 

Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 12
Healthcare Sector # 5
Overall # 34

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
196.76 %
31.03 %
-74.18 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry # 12
Sector # 28
S&P 500 # 229
Cumulative Capital Expenditures growth Comment
Zimmer Biomet Holdings Inc showed decline, but improvement compare to trailing twelve month Capital Expenditures decrease in Jun 30 2024. If the fiscal year would end in Sep 30 2024, Zimmer Biomet Holdings Inc 's annual Capital Expenditures drop would be -11.48% year on year to $335 millions.

Among companies within the Healthcare sector 4 other companies have achieved higher trailing twelve month Capital Expenditures growth. While Total ranking has impoved so far to 34, from total ranking in previous quarter at 310.

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
196.76 %
31.03 %
-74.18 %
 


Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 12
Healthcare Sector # 5
Overall # 34

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
196.76 %
31.03 %
-74.18 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry # 12
Sector # 28
S&P 500 # 229




Other Capital Expenditures Growth
Medical Equipment & Supplies Industry Capital Expenditures Growth Trends and Statistics
Healthcare Sector Capital Expenditures Growth Statistics
Capital Expenditures Growth Trends for overall market
ZBH's Capital Expenditures Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Capital Expenditures Growth
Lowest Ranking Capital Expenditures Growth
Capital Expenditures Growth for ZBH's Competitors
Capital Expenditures Growth for Zimmer Biomet Holdings Inc 's Suppliers
Capital Expenditures Growth for ZBH's Customers

You may also want to know
ZBH's Annual Growth Rates ZBH's Profitability Ratios ZBH's Asset Turnover Ratio ZBH's Dividend Growth
ZBH's Roe ZBH's Valuation Ratios ZBH's Financial Strength Ratios ZBH's Dividend Payout Ratio
ZBH's Roa ZBH's Inventory Turnover Ratio ZBH's Growth Rates ZBH's Dividend Comparisons



Companies with similar Capital Expenditures drop for the quarter ending Sep 30 2024 within Healthcare SectorY/Y Change %Capital Expenditures for the quarter ending Sep 30 2024
Livanova Plc108.16%$ 108.156 millions
Bausch and Lomb Corp100.00%$ 100.000 millions
Globus Medical Inc 94.82%$ 94.817 millions
Amphastar Pharmaceuticals Inc 94.61%$ 94.614 millions
Enovis Corp89.37%$ 89.371 millions
Opko Health Inc 88.84%$ 88.841 millions
Denali Therapeutics Inc 87.81%$ 87.814 millions
Inozyme Pharma Inc 85.71%$ 85.714 millions
Rhythm Pharmaceuticals inc 83.15%$ 83.150 millions
Guardant Health Inc 77.02%$ 77.024 millions
Rxsight Inc 68.91%$ 68.913 millions
Zimmer Biomet Holdings Inc 68.48%$ 68.480 millions
Vertex Pharmaceuticals Inc66.75%$ 66.749 millions
Pulse Biosciences Inc 65.22%$ 65.217 millions
Cadre Holdings inc 64.75%$ 64.751 millions
Brookdale Senior Living Inc 64.22%$ 64.222 millions
Penumbra Inc63.60%$ 63.595 millions
Incyte Corporation61.14%$ 61.142 millions
Bausch Health Companies Inc 54.35%$ 54.348 millions
Viemed Healthcare Inc 48.64%$ 48.636 millions
Acadia Healthcare Company Inc 48.57%$ 48.565 millions
Biogen Inc 48.40%$ 48.402 millions
Travere Therapeutics Inc 47.36%$ 47.365 millions
Eli Lilly And Company39.20%$ 39.204 millions
Revolution Medicines Inc 38.86%$ 38.856 millions
Align Technology inc 37.72%$ 37.721 millions
Regeneron Pharmaceuticals Inc 37.44%$ 37.443 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com